
Wicklow adventurer to take on 750km cycling challenge for charity
Now he has set himself a new challenge, involving a 750km cycle across France.
'A few years ago I got back on my bike and set myself a challenge of cycling 160km event. I applied to take part in the Ring of Clare and was hooked, I decided to raise money for a local charity and I called into Wicklow Cancer Support and raised over €2,000 for them.
'Now this September, I'm trading my comfy couch for a bike seat and embarking on a six-day cycling odyssey from Paris to Nice, because why not go big or go home,' said Nigel.
The charity ride starts on September 6, and Nigel is under no illusions over just how challenging the venture will prove, from both a mental and physical perspective.
'I'll be tackling everything from the charming streets of Montargis to the legendary climbs of Mount Ventoux. It's a journey that promises to test my legs, my resolve, and my ability to pronounce French town names correctly.
'But this isn't just about proving I can survive on energy gels and questionable French pastries. I'm pedalling for a purpose: raising funds for the Alzheimer's Society of Ireland. This cause is close to my heart, as my family, like many others, has been touched by the challenges of Alzheimer's.'
In Ireland, approximately 64,000 people are currently living with dementia. This number is projected to more than double by 2045, reaching an estimated 150,131, due to the increasing and aging population.
Nigel has established an idonate page to help raise funds for the Alzheimer's Society of Ireland and will be covering all the costs associated with the trip from his own pocket.
He added: 'I'm covering all my own costs, so every euro you donate goes straight to supporting vital services and research for those affected by dementia in Ireland. With 11,000 new cases diagnosed each year, and numbers expected to rise, your support is more important than ever.'
Nigel will be sharing regular updates on his training progress, and once he sets off on his journey, he will also provide daily updates from the event itself.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Examiner
9 hours ago
- Irish Examiner
Dementia: Can statins keep your brain sharp?
Statins are not the most popular drugs, with many people who take them as a matter of necessity to keep their cholesterol under control, often grumbling about muscle twinges and joint aches. But earlier this year, a new study appeared to provide another compelling reason to take them. Based on data collected from more than 570,000 South Koreans, it concluded that taking statins reduces your risk of dementia in later life by 13%. With more than 64,000 people in Ireland currently suffering from dementia, figures which are predicted to more than double over the next 20 years, every little reduction in risk helps. Dr Angie Brown, Irish Heart Foundation According to Angie Brown, a consultant cardiologist and medical director for the Irish Heart Foundation, one of the main theories behind this benefit is because statins can improve so-called 'vascular health,' which refers to the functioning of the complex network of blood vessels which connect the brain with the rest of the body. While they are best knowing for lowering the levels of LDL cholesterol — the harmful form of cholesterol — reducing risk of plaques forming and blocking veins and arteries, they are also believed to reduce inflammation, and improve function of endothelial cells, the thin layer of tissue lining blood vessels which helps your blood move smoothly through your body. 'Vascular health is important,' says Brown. 'Problems with blood vessels such as those caused by plaque build-up or the stiffening which can occur with age, can restrict blood flow to the brain, reducing oxygen supply which is crucial for cellular function. Narrowing of the carotid arteries [the pair of major blood vessels in the neck] can lead to mini strokes which can lead to dementia.' While this may imply that statins might be most beneficial for stopping vascular dementia, the South Korean study found that the greatest benefit was actually seen in preventing Alzheimer's disease. While deteriorating vascular health plays an often overlooked role in the development and progression of Alzheimer's, an additional possible explanation has been offered by other studies which have suggested that statins may limit production of the toxic beta amyloid protein, one of the underlying causes of Alzheimer's. Another idea is linked to the so-called 'lipid invasion model' of Alzheimer's disease, an emerging theory based on research which has indicated that the blood-brain barrier, the protective layer of cells which shields the brain from the bloodstream, can become more permeable as we age, enabling excess LDL cholesterol molecules to slip through with damaging consequences. 'This is a newer idea but it's quite interesting,' says Professor Sean Kennelly, a consultant geriatrician at Tallaght University Hospital. 'As we get older, the weakening protective barrier between the brain and the rest of the body may allow harmful cholesterol particles to leak into the brain, where they could trigger damage and inflammation. It would explain why statins might protect the brain. It's still being studied but it's a possibility.' So shouldn't we all get ourselves on statins in midlife, and accept the odd twinge in exchange for a sharper and healthier brain in old age? Not so fast, says Kennelly, who points out that while statins are known to have clear benefits for heart health, doctors need more evidence to be convinced that they can do the same for the brain. He explains that the South Korean study was a so-called observational study where large groups of people are tracked over time. However, such studies cannot conclusively prove that statins are driving benefits for the brain because other factors such as overall health may have proved a way. 'In contrast, clinical trials, which are the gold standard for testing treatments, where people have been randomly assigned to take statins or not, have not shown strong or consistent evidence that statins slow cognitive decline or prevent dementia,' says Kennelly. 'However, many didn't follow participants for long enough to fully assess dementia risk.' With that in mind, Kennelly feels that for now, lifestyle measures such as regular exercise and healthy eating to manage your blood pressure and blood sugar, along with staying socially connected and looking after your hearing, remain the best strategies for protecting your brain health through midlife and old age. Other research has also pointed out that the shingles vaccine seems to be another potential preventative measure against dementia. His thoughts are echoed by Geir Selbæk, a professor at the Norwegian National Centre for Ageing and Health, commonly known as Norway's leading dementia expert. Geir Selbæk, a professor at the Norwegian National Centre for Ageing and Health While Selbæk, 61, does take statins, he did so only because of a family history of heart disease. Like Kennelly, he is not completely convinced that statins alone are enough to stave off dementia, and instead, he is focusing more on other measures such as starting to wear a hearing aid after noticing early signs of deafness, regularly running and doing strength training as both are linked with better brain health, and stimulating his mind by training to learn a new language. 'We also have to take into account whether taking statin in the hope of a 13% risk reduction of dementia in 20 years time is worth it for a person,' he says. 'Especially if you have side effects like stiff joints.' However with the advent of AI in healthcare, Selbæk predicts that in future computer models will be able to predict with increasing accuracy, the midlifers who might be able to benefit most from these drugs for their brain health. 'In the future we'll also likely have better tests, maybe blood tests or brain scans, that can show who's most at risk,' says Kennelly. 'That could help doctors decide more precisely who would benefit from interventions like statins.'


Irish Independent
2 days ago
- Irish Independent
Almost $10m worth of contraceptives set to be torched by US as part of cuts to foreign aid
Governments and family planning providers in France and Belgium – where the items were held in a warehouse – have been scrambling to block the US from destroying the supplies. The products, which include contraceptive pills, implants and IUDs (intrauterine devices or coils) and have already been paid for by US taxpayers, are being sent to a specialist facility to be incinerated, at an additional cost of $167,000. That's despite offers from charities including MSI Reproductive Choices and the International Planned Parenthood Federation (IPPF) to take on the costs of donating the contraception. The Belgian ministry of foreign affairs had also said it was, 'exploring all possible avenues to prevent the destruction of these stocks, including their temporary relocation'. A ministry spokesperson said the department had acted as soon as the plans to destroy stocks of contraception came to its attention – including sending formal diplomatic representations to the US embassy. French member of parliament Soumya Bourouaha asked in an official question on Monday for the prime minister to, 'do everything possible to save these contraceptive stocks and deliver them to the populations who need them'. However, the negotiations faltered, The Independent understands. The supplies are understood to now be in the process of being transferred between the two countries. Unintended pregnancies in countries with high maternal mortality and no access to safe abortion can be a death sentence. Research by the Guttmacher Institute, a reproductive rights research group, has found the $600m spent on family planning overseas by the US government last year prevented 34,000 maternal deaths and over five million unsafe abortions. The contraception was purchased under a contract managed by development firm Chemonics, which has been partly cancelled as part of the Donald Trump's deep cuts to foreign aid. Two family planning charities said they had been told by representatives of the project that the destruction of contraceptives was part of an effort to save money, despite the fact the supplies have already been paid for. MSI's associate advocacy director Sarah Shaw said: 'This isn't about government efficiencies. This is about exporting an ideology that's harmful to women.' To give one example, she said, 'the annual contraceptive bill for Senegal for the entire country is $3m dollars a year'. 'So the contents of that warehouse could have met all of Senegal's contraceptive needs for three years. And instead we're going to see massive shortages. 'We're going to see Senegalese women dying of unsafe abortion, girls having to drop out of school,' she said.


Irish Independent
2 days ago
- Irish Independent
Almost $10m worth of contraceptives set to be torched by US as part of cuts to foreign aid
Governments and family planning providers in France and Belgium – where the items were held in a warehouse – have been scrambling to block the US from destroying the supplies. The products, which include contraceptive pills, implants and IUDs (intrauterine devices or coils) and have already been paid for by US taxpayers, are being sent to a specialist facility to be incinerated, at an additional cost of $167,000. That's despite offers from charities including MSI Reproductive Choices and the International Planned Parenthood Federation (IPPF) to take on the costs of donating the contraception. The Belgian ministry of foreign affairs had also said it was, 'exploring all possible avenues to prevent the destruction of these stocks, including their temporary relocation'. A ministry spokesperson said the department had acted as soon as the plans to destroy stocks of contraception came to its attention – including sending formal diplomatic representations to the US embassy. French member of parliament Soumya Bourouaha asked in an official question on Monday for the prime minister to, 'do everything possible to save these contraceptive stocks and deliver them to the populations who need them'. However, the negotiations faltered, The Independent understands. The supplies are understood to now be in the process of being transferred between the two countries. Unintended pregnancies in countries with high maternal mortality and no access to safe abortion can be a death sentence. Research by the Guttmacher Institute, a reproductive rights research group, has found the $600m spent on family planning overseas by the US government last year prevented 34,000 maternal deaths and over five million unsafe abortions. The contraception was purchased under a contract managed by development firm Chemonics, which has been partly cancelled as part of the Donald Trump's deep cuts to foreign aid. Two family planning charities said they had been told by representatives of the project that the destruction of contraceptives was part of an effort to save money, despite the fact the supplies have already been paid for. MSI's associate advocacy director Sarah Shaw said: 'This isn't about government efficiencies. This is about exporting an ideology that's harmful to women.' To give one example, she said, 'the annual contraceptive bill for Senegal for the entire country is $3m dollars a year'. 'So the contents of that warehouse could have met all of Senegal's contraceptive needs for three years. And instead we're going to see massive shortages. 'We're going to see Senegalese women dying of unsafe abortion, girls having to drop out of school,' she said.